Hollencrest Capital Management Glaukos Corp Transaction History
Hollencrest Capital Management
- $2.36 Billion
- Q3 2024
A detailed history of Hollencrest Capital Management transactions in Glaukos Corp stock. As of the latest transaction made, Hollencrest Capital Management holds 5 shares of GKOS stock, worth $741. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 5
-0.0%
Holding current value
$741
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
341Shares Held
46.8MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.19 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$871 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$324 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$290 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$243 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $7.06B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...